Inside the Beltway: Weekly US Politics Decoded

President Donald Trump is suing the United States government for ten billion dollars... and a federal judge just pointed out that he is suing agencies he himself controls. The lawsuit, filed over a 2020 tax record leak, now faces a fundamental question from US District Judge Kathleen Williams: can a president sue his own administration? The judge has delayed the government's response, setting a hearing for May twenty-seventh to determine if a legitimate legal dispute can even exist when the plaintiff is also the defendant's boss. This dynamic of a president testing the boundaries of the system is now playing out across Washington. Last week, it was the Federal Reserve's turn.

Trump's nominee for Fed Chair, Kevin Warsh, faced a brutal Senate confirmation hearing on April twenty-first. Senator Elizabeth Warren labeled Warsh a "sock puppet" for the president, warning his confirmation would aid an "illegal takeover of the Fed." Warsh defended his independence, but the battle lines are clear. The question is no longer just about interest rates—it’s about whether the central bank can remain insulated from direct political pressure ahead of the November midterms. While one branch of government pushes back and another braces for a fight, Trump is using direct executive power to force change elsewhere. On April eighteenth, he issued an executive order to accelerate FDA approval for psychedelic medicines.

The order creates "national priority vouchers" to speed up reviews and directs the DEA to reschedule drugs once they are approved. The market reaction was immediate. Stocks for biotech firms like Enveric Biosciences surged nearly two hundred percent. The move bypasses the slow grind of the normal approval process, using presidential authority to create a new reality for an entire industry overnight. Meanwhile, Congress is running into its old enemy: the calendar. The Clarity Act, a major crypto regulation bill, has strong bipartisan support. It passed the House with a big margin back in July 2025. But it's now April 2026, and the bill is stuck.

According to an analysis by Galaxy Digital's Alex Thorn, if the bill doesn't get moving by mid-May, its chances of passing this year drop to fifty-fifty, or even lower. The legislative process is simply too slow for the political season. This isn't the only deadline creating pressure. A federal ban on intoxicating hemp products is set to take effect on November thirteenth, threatening a multi-billion-dollar industry. In response, Senator Rand Paul just introduced the Hemp Safety Enforcement Act. His bill would let states and tribes set their own rules, effectively nullifying the federal ban and preserving thousands of jobs. It’s a direct challenge to federal overreach, initiated from within the Senate itself.

Here's the turn. While all eyes are on these federal power struggles—the President versus the courts, the Fed, and the regulatory state—the political ground is shifting somewhere else entirely. In California's fortieth congressional district, a state-level proposition just forced two incumbent Republicans, Ken Calvert and Young Kim, to run against each other. This created an opening. The Democratic candidate, Esther Kim-Varet, just reported she has one-point-one-five million dollars in cash on hand, raised mostly from small-dollar donors. While Washington argues about the rules of the game, a state ballot measure has completely redrawn the board in a key congressional district.

So the real story this week isn't just about a president testing the limits of his power. It's about where power actually resides. We see Trump using executive orders to create new markets, and we see Congress trying—and often failing—to keep up. We see a president suing himself. But the most significant change might be coming from a local campaign finance report in Southern California, proving that the most durable shifts in power often start far from the White House. The game is changing, but not just at the top.